OPAL Therapeutics

About:

OPAL Therapeutics develops therapies for the treatment of human immunodeficiency virus, hepatitis C and chronic infection.

Top Investors: Alta Partners, Alloy Ventures, GBS Ventures, Uniseed

Description:

OPAL Therapeutics Pty Limited operates as an immunotherapy development company in Australia. It develops therapies for the treatment of human immunodeficiency virus, Hepatitis C, and chronic infection. OPAL Therapeutics Pty Limited was incorporated in 2005 and is based in Melbourne, Australia.